These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 38812298)
1. Development of a Risk Model and Genotyping Patterns Based on Disulfidptosis-Related lncRNAs to Predict Prognosis and Immune Landscape in Osteosarcoma. Zhang K; Lu S; Jiang M; Zou X; Chen C; Lan Y; Zhao H; Ma R; Yan H Front Biosci (Landmark Ed); 2024 May; 29(5):193. PubMed ID: 38812298 [TBL] [Abstract][Full Text] [Related]
2. Develop a Novel Signature to Predict the Survival and Affect the Immune Microenvironment of Osteosarcoma Patients: Anoikis-Related Genes. Yang M; Su Y; Xu K; Zheng H; Cai Y; Wen P; Yang Z; Liu L; Xu P J Immunol Res; 2024; 2024():6595252. PubMed ID: 39431237 [TBL] [Abstract][Full Text] [Related]
3. Prediction of Prognosis and Immunotherapy Response with a Novel Natural Killer Cell Marker Genes Signature in Osteosarcoma. Li Q; Huang X; Zhao Y Cancer Biother Radiopharm; 2024 Sep; 39(7):502-516. PubMed ID: 37889617 [No Abstract] [Full Text] [Related]
4. A novel signature to guide osteosarcoma prognosis and immune microenvironment: Cuproptosis-related lncRNA. Yang M; Zheng H; Xu K; Yuan Q; Aihaiti Y; Cai Y; Xu P Front Immunol; 2022; 13():919231. PubMed ID: 35967366 [TBL] [Abstract][Full Text] [Related]
5. Identification of cuproptosis-related lncRNA prognostic signature for osteosarcoma. Liu B; Liu Z; Feng C; Li C; Zhang H; Li Z; Tu C; He S Front Endocrinol (Lausanne); 2022; 13():987942. PubMed ID: 36313774 [TBL] [Abstract][Full Text] [Related]
6. N6-Methyladenosine-Related LncRNAs Are Potential Remodeling Indicators in the Tumor Microenvironment and Prognostic Markers in Osteosarcoma. Wu Z; Zhang X; Chen D; Li Z; Wu X; Wang J; Deng Y Front Immunol; 2021; 12():806189. PubMed ID: 35095893 [TBL] [Abstract][Full Text] [Related]
7. Comprehensive investigation of tumor immune microenvironment and prognostic biomarkers in osteosarcoma through integrated bulk and single-cell transcriptomic analysis. Shi S; Zhang L; Guo X Front Immunol; 2024; 15():1424950. PubMed ID: 39108264 [TBL] [Abstract][Full Text] [Related]
8. Ferroptosis-related lncRNAs guiding osteosarcoma prognosis and immune microenvironment. Yang M; Su Y; Xu K; Zheng H; Yuan Q; Cai Y; Aihaiti Y; Xu P J Orthop Surg Res; 2023 Oct; 18(1):787. PubMed ID: 37858131 [TBL] [Abstract][Full Text] [Related]
9. N6-methyladenosine Modification-Related Long Non-Coding RNAs are Potential Biomarkers for Predicting the Prognosis of Patients With Osteosarcoma. Yang K; Wang F; Li K; Peng G; Yang H; Xu H; Xiang Y; Sun H Technol Cancer Res Treat; 2022; 21():15330338221085354. PubMed ID: 35422168 [No Abstract] [Full Text] [Related]
10. Comprehensive analysis of prognostic tumor microenvironment-related genes in osteosarcoma patients. Hu C; Liu C; Tian S; Wang Y; Shen R; Rao H; Li J; Yang X; Chen B; Ye L BMC Cancer; 2020 Aug; 20(1):814. PubMed ID: 32854645 [TBL] [Abstract][Full Text] [Related]
11. Transcriptome and single-cell analysis reveal disulfidptosis-related modification patterns of tumor microenvironment and prognosis in osteosarcoma. Wang L; Liu Y; Tai J; Dou X; Yang H; Li Q; Liu J; Yan Z; Liu X Sci Rep; 2024 Apr; 14(1):9186. PubMed ID: 38649690 [TBL] [Abstract][Full Text] [Related]
12. The tumor immune microenvironment and immune-related signature predict the chemotherapy response in patients with osteosarcoma. He L; Yang H; Huang J BMC Cancer; 2021 May; 21(1):581. PubMed ID: 34016089 [TBL] [Abstract][Full Text] [Related]
13. Construction of a Novel Disulfidptosis-Related lncRNA Prognostic Signature in Pancreatic Cancer. Xing F; Qin Y; Xu J; Wang W; Zhang B Mol Biotechnol; 2024 Sep; 66(9):2396-2414. PubMed ID: 37733182 [TBL] [Abstract][Full Text] [Related]
14. A risk assessment model for the prognosis of osteosarcoma utilizing differentially expressed lncRNAs. Sun K; Zhao J Mol Med Rep; 2019 Feb; 19(2):1128-1138. PubMed ID: 30569146 [TBL] [Abstract][Full Text] [Related]
15. Development of an immune-related prognostic index associated with osteosarcoma. Yin CD; Hou YL; Liu XR; He YS; Wang XP; Li CJ; Tan XH; Liu J Bioengineered; 2021 Dec; 12(1):172-182. PubMed ID: 33371790 [TBL] [Abstract][Full Text] [Related]
16. Development of a novel disulfidptosis-related lncRNA signature for prognostic and immune response prediction in clear cell renal cell carcinoma. Wang N; Hu Y; Wang S; Xu Q; Jiao X; Wang Y; Yan L; Cao H; Shao F Sci Rep; 2024 Jan; 14(1):624. PubMed ID: 38182642 [TBL] [Abstract][Full Text] [Related]
17. Identification of novel disulfidptosis-related lncRNA signatures to predict the prognosis and immune microenvironment of skin cutaneous melanoma patients. Cheng S; Wang X; Yang S; Liang J; Song C; Zhu Q; Chen W; Ren Z; Zhu F Skin Res Technol; 2024 Jul; 30(7):e13814. PubMed ID: 38924611 [TBL] [Abstract][Full Text] [Related]
18. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer. Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X Front Immunol; 2022; 13():1056932. PubMed ID: 36479114 [TBL] [Abstract][Full Text] [Related]
19. Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of osteosarcoma cancer. Liu R; Hu Y; Liu T; Wang Y BMC Cancer; 2021 Dec; 21(1):1345. PubMed ID: 34922489 [TBL] [Abstract][Full Text] [Related]
20. N6-methylandenosine-related lncRNAs play an important role in the prognosis and immune microenvironment of pancreatic ductal adenocarcinoma. Hu Y; Chen Y Sci Rep; 2021 Sep; 11(1):17844. PubMed ID: 34497315 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]